Mechanisms of estrogenic vascular protection

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 2, 2006, Pages

  Jayachandran, Muthuvel ^a   Miller, Virginia M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL 3 METHYL ETHER; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MEDROXYPROGESTERONE ACETATE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN P85; PROTEIN SH2; RAC1 PROTEIN;

ATHEROSCLEROSIS; CLINICAL TRIAL; DRUG MECHANISM; EDITORIAL; HEART INFARCTION; HEART PROTECTION; HUMAN; MENOPAUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STROKE; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD VESSEL; CELL PROTECTION; NOTE; PHYSIOLOGY;

ANIMALS; BLOOD VESSELS; CYTOPROTECTION; ESTROGENS; HUMANS;

EID: 33644858318     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01086.2005     Document Type: Editorial

References (28)

1. American Heart Association. Heart Disease and Stroke Statistics - 2003 Update. Dallas, TX: American Heart Association, 2002.
2. Barrett-Connor E and Bush TL. Estrogen and coronary heart disease in women. JAMA 265: 1861-1867, 1991.
3. Bracamonte MP, Rud KS, Owen WG, and Miller VM. Ovariectomy increases mitogens and platelet-induced proliferation of arterial smooth muscle. Am J Physiol Heart Circ Physiol 283: H853-H860, 2002.
4. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, and Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75: 1102-1109, 1987.
5. Clarkson TB and Appt SE. Coronary artery disease and postmenopausal hormone therapy: is there a time window for prevention? Gynaecol Forum 9: 11-14, 2004.
6. Criqui MH, Suarez L, Barrett-Connor E, McPhillips J, Wingard DL, and Garland C. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. Am J Epidemiol 128: 606-614, 1988.
7. Del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RGW, and Schwartz MA. Integrins regulate Rac targeting by internalization of membrane domains. Science 303: 839-842, 2004.
8. Dubey RK, Tofovic SP, and Jackson EK. Cardiovascular pharmacology of estradiol metabolites. J Pharmacol Exp Ther 308: 403-409, 2004.
9. Finlay GA, Hunter DS, Walker CL, Paulson KE, and Fanburg BL. Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expression. Am J Physiol Cell Physiol 285: C409-C418, 2003.
10. Geraldes P, Sirois MG, and Tanguay JF. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res 93: 399-405, 2003.
11. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, and Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335: 453-461, 1996.
12. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, and Santoro N. KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 8: 3-12, 2005.
13. Hodges YK, Tung L, Yan XD, Graham D, Horwitz KB, and Horwitz LD. Estrogen receptors α and β. Prevalence of estrogen receptor β mRNA in human vascular smooth muscle and transcriptional effects. Circulation 101: 1792-1798, 2000.
14. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, and Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613, 1998.
15. Jayachandran M, Hayashi T, Sumi D, Iguchi A, and Miller VM. Temporal effects of 17β-estradiol on caveolin-1 mRNA and protein in bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 281: H1327-H1333, 2001.
16. Jayachandran M, Mukherjee R, Steinkamp T, LaBreche P, Bracamonte MP, Okano H, Owen WG, and Miller VM. Differential effects of 17β-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets. Am J Physiol Heart Circ Physiol 288: H2355-H2362, 2005.
17. Kappert K, Caglayan E, Huntgeburth M, Bäumer AT, Sparwel J, Uebel M, and Rosenkranz S. 17β-Estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. Am J Physiol Heart Circ Physiol 290: H538-H546, 2006.
18. Karas RH, Gauer EA, Bieber HE, Baur WE, and Mendelsohn ME. Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway. J Clin Invest 101: 2851-2861, 1998.
19. Kedl RM and Mescher MF. Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response. J Immunol 161: 674-683, 1998.
20. Laufs U, Adam O, Strehlow K, Wassmann S, Konkol C, Laufs K, Schmidt W, Bohm M, and Nickenig G. Down-regulation of Rac-1 GTPase by estrogen. J Biol Chem 278: 5956-5962, 2003.
21. Liu PY, Death AK, and Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 24: 313-340, 2003.
22. Mendelsohn ME and Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583-1587, 2005.
23. Miller VM, Tindall DJ, and Liu PY. Of mice, men, and hormones. Arterioscler Thromb Vasc Biol 24: 995-997, 2004.
24. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH, Mendelsohn ME, Housman DE, and Levy D. Association between estrogen receptor α gene variation and cardiovascular disease. JAMA 290: 2263-2270, 2003.
25. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP, Malloy MJ, Korach KS, and Rubanyi GM. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 96: 3774-3777, 1997.
26. Sudhir K and Komesaroff PA. Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab 84: 3411-3415, 1999.
27. Watanabe T, Akishita M, Nakaoka T, Hong H, Miyahara Y, Yamashita N, Wada Y, Aburatani H, Yoshizumi M, Kozaki K, and Ouchi Y. Caveolin-1, Id3a and two LIM protein genes are upregulated by estrogen in vascular smooth muscle cells. Life Sci 75: 1219-1229, 2004.
28. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333, 2002.